- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Kelly Rogers
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Melissa Call
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Shalin Naik
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor Daniel Gray
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jeanne Tie
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marnie Blewitt
- Professor Matthew Ritchie
- Professor Melanie Bahlo
- Professor Melissa Davis
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Czabotar
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sandra Nicholson
- Professor Sant-Rayn Pasricha
- Professor Seth Masters
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A multi-pronged approach to targeting myeloproliferative neoplasms
- A new paradigm of machine learning-based structural variant detection
- A whole lot of junk or a treasure trove of discovery?
- Advanced imaging interrogation of pathogen induced NETosis
- Analysing the metabolic interactions in brain cancer
- Atopic dermatitis causes and treatments
- Boosting the efficacy of immunotherapy in lung cancer
- Building a cell history recorder using synthetic biology for longitudinal patient monitoring
- Characterisation of malaria parasite proteins exported into infected liver cells
- Deciphering the heterogeneity of the tissue microenvironment by multiplexed 3D imaging
- Defining the mechanisms of thymic involution and regeneration
- Delineating the molecular and cellular origins of liver cancer to identify therapeutic targets
- Developing computational methods for spatial transcriptomics data
- Developing drugs to block malaria transmission
- Developing models for prevention of hereditary ovarian cancer
- Developing statistical frameworks for analysing next generation sequencing data
- Development and mechanism of action of novel antimalarials
- Development of novel RNA sequencing protocols for gene expression analysis
- Discoveries in red blood cell production and function
- Discovering epigenetic silencing mechanisms in female stem cells
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Dissecting mechanisms of cytokine signalling
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- Epigenetic biomarkers of tuberculosis infection
- Epigenetics – genome wide multiplexed single-cell CUT&Tag assay development
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Exploiting the cell death pathway to fight Schistosomiasis
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- How do nutrition interventions and interruption of malaria infection influence development of immunity in sub-Saharan African children?
- Human lung protective immunity to tuberculosis
- Improving therapy in glioblastoma multiforme by activating complimentary programmed cell death pathways
- Innovating novel diagnostic tools for infectious disease control
- Integrative analysis of single cell RNAseq and ATAC-seq data
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigation of a novel cell death protein
- Malaria: going bananas for sex
- Mapping spatial variation in gene and transcript expression across tissues
- Mechanisms of Wnt secretion and transport
- Multi-modal computational investigation of single-cell communication in metastatic cancer
- Nanoparticle delivery of antibody mRNA into cells to treat liver diseases
- Naturally acquired immune response to malaria parasites
- Organoid-based discovery of new drug combinations for bowel cancer
- Organoid-based precision medicine approaches for oral cancer
- Removal of tissue contaminations from RNA-seq data
- Reversing antimalarial resistance in human malaria parasites
- Role of glycosylation in malaria parasite infection of liver cells, red blood cells and mosquitoes
- Screening for novel genetic causes of primary immunodeficiency
- Single-cell ATAC CRISPR screening – Illuminate chromatin accessibility changes in genome wide CRISPR screens
- Spatial single-cell CRISPR screening – All in one screen: Where? Who? What?
- Statistical analysis of single-cell multi-omics data
- Structural and functional analysis of epigenetic multi-protein complexes in genome regulation
- Structural basing for Wnt acylation
- Structure, dynamics and impact of extra-chromosomal DNA in cancer
- Targeted deletion of disease-causing T cells
- Targeting cell death pathways in tissue Tregs to treat inflammatory diseases
- The cellular and molecular calculation of life and death in lymphocyte regulation
- The role of hypoxia in cell death and inflammation
- The role of ribosylation in co-ordinating cell death and inflammation
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding cellular-cross talk within a tumour microenvironment
- Understanding the genetics of neutrophil maturation
- Understanding the roles of E3 ubiquitin ligases in health and disease
- Unveiling the heterogeneity of small cell lung cancer
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to understand malaria invasion and transmission
- Using structural biology to understand programmed cell death
- Validation and application of serological markers of previous exposure to malaria
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Ashley Weir
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jasmine Rou
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Krishneel Prasa
- Lilly Backshell
- Malvika Kharbanda
- Megan Kent
- Naomi Jones
- Pailene Lim
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Sophie Collard
- Wayne Cawthorne
- Wil Lehmann
- Yanxiang Meng
- Zhong Yan Gan
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A generous vision for impactful medical research
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Philanthropy through the power of sisterhood
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- Donors
- WEHI.TV
Sir Frank Macfarlane Burnet

Director, 1944-1965
Nobel Laureate Sir Frank Macfarlane Burnet is considered one of the twentieth century's greatest scientists, and a true scientific hero.
At a time when most talented young Australian scientists left for international positions, Sir Macfarlane Burnet remained in Australia and played a pivotal role in helping to build the field of medical research in this country.
He made significant contributions to bacteriology, virology and immunology over his 59-year career, most of which was spent here at the Walter and Eliza Hall Institute.
During Sir Macfarlane Burnet's term as director, the institute expanded in size, scope and profile. Midway through his term as director, a change in research focus and breakthrough discoveries established the institute as a world leader in immunology research.
Basic science and clinical medicine
A medical graduate, Sir Macfarlane Burnet was determined to foster a strong connection between basic science and clinical medicine, a focus that continues at the institute to this day.
as institute director, Dr Charles Kellaway
Sir Macfarlane Burnet's initial appointment at the Walter and Eliza Hall Institute was as a pathology registrar, under our first director, Dr Sydney Patterson. Dr Patterson's successor, Dr Charles Kellaway, encouraged Sir Macfarlane Burnet to pursue research qualifications in the United Kingdom, where he trained in microbiology from 1925 to 1928.
In 1928 Sir Macfarlane Burnet returned to the institute, where he remained until his retirement in 1965. He succeeded Dr Kellaway as director in 1944.
One of his first actions as director was to establish a Clinical Research Unit. He ensured that the unit had its own ward within the new Royal Melbourne Hospital and appointed as its head the well-known gastroenterologist, Dr Ian Wood.
Building a world-class scientific community in Australia
Sir Macfarlane Burnet made several notable appointments during his tenure, including biochemists Dr Alfred Gottschalk and Professor Gordon Ada, and virologists Professor Frank Fenner, Dr Eric French and Dr Stephen Fazekas. The growing reputation of the institute also drew an increasing number of visiting scientists from overseas.
During the Burnet era, many younger scientists also developed their careers at the institute. These included Professor Donald Metcalf and Sir Gustav Nossal.
Professor Phil Hodgkin, head of our Immunology division, wrote of Sir Macfarlane Burnet’s role in developing a strong medical research community in Australia:
“Burnet is remembered as an intuitive thinker and a great example of an eclectic statesman scientist… However, Australians remember Sir Mac for another important reason. While science is ultimately shared and free of boundaries, Burnet seems to have realized early in his career that he could play a role in the development of medical research in the young country of Australia.
“He chose to work in Melbourne, breaking the pattern of the day for the brightest Australians to work in Britain. As a result, medical researchers collected around him, and his fertile imagination and ideas seeded new directions to explore and gave confidence to ensuing generations of Australian scientists.”
Research focus
An eminent virologist and microbiologist, Sir Macfarlane Burnet made important discoveries about significant viral diseases of the era including influenza, herpes, poliomyelitis and Murray Valley Encephalitis (MVE), as well as bacterial diseases including psittacosis and Q fever, the causative agent of which, Coxiella burnetii, was named in his honour.
innoculation of eggs with influenza virus
At the outbreak of World War II, Sir Macfarlane Burnet focused the institute’s research program on producing an influenza vaccine, to counter the potential for a repeat of the devastating influenza pandemic in the aftermath of World War I.
He also expanded the institute’s research effort into tropical infections including scrub typhus, a disease that was prevalent in Australian troops in North Queensland and New Guinea. This research claimed the life of a promising colleague, Miss Dora Lush.
In the early 1950s, Dr Eric French and Sir Macfarlane Burnet proved an outbreak of encephalitis in the Mildura region was due to MVE and not, as feared, the myxomatosis virus that had just been released to control rabbits. Famously, Sir Macfarlane Burnet, Professor Frank Fenner and Sir Ian Clunies-Ross allayed public fears by inoculating themselves with myxomatosis virus, demonstrating it had no effect on humans.
From virology to immunology
Sir Macfarlane Burnet's research into infectious diseases had included forays into studying the immune response to infectious agents. In the 1940s, he had become to publish his research and theories in how the immune system functions.
By 1957, Sir Macfarlane Burnet had decided that immunology research was an area of huge importance. Almost overnight, immunology became the major preoccupation of the institute.
Sir Gustav Nossal, who arrived at the institute in 1957, and later succeeded Burnet as director, later recalled,
“I had come to work under the world’s greatest virologist, Sir Macfarlane Burnet… but to my dismay, Burnet was phasing out virus work, turning the institute almost entirely towards immunology. Little did I realise that he had climbed onto a huge wave that was just about to break, propelling us younger workers into a glorious future.”
Sir Macfarlane Burnet’s decision soon placed the institute at the forefront of global immunology research, with almost 50 per cent of the world immunology literature coming from the institute in the next decade.
An Australian Nobel laureate
In 1959, Sir Macfarlane Burnet published a seminal paper describing his clonal selection theory of antibody production. The theory revolutionised our understanding of the immune system, and to this day it underpins our understanding of disease and the way our bodies respond to it.
jointly awarded the 1960 Nobel Prize in Physiology or Medicine
Sir Macfarlane Burnet’s research into immune tolerance - how our immune system avoids attacking our body's tissues - saw him awarded the 1960 Nobel Prize for Physiology or Medicine with his collaborator, Sir Peter Medawar.
On his retirement in 1965, Sir Macfarlane Burnet was succeeded by his protégé, Sir Gustav Nossal. His enormous impact on scientific understanding, and on delivering the institute to international prominence, remains his enduring legacy.
Awards and honours
In addition to the Nobel Prize, Sir Frank Macfarlane Burnet’s scientific genius has been recognised by many international and Australian awards.
Sir Macfarlane Burnet was the first recipient of the Australian of the Year title. When told of the honour, he said,
“it does indicate that the community thinks that science is important, which pleases me.”
Sir Macfarlane Burnet’s legacy has been honoured in many ways. He has been commemorated on several Australian stamps, and even a Melbourne tram.
Since 1971 the Australian Academy of Science has awarded The Macfarlane Burnet Medal to outstanding scientists.
In 1986 the new Burnet Institute was named in honour of Sir Macfarlane Burnet, following his commitment to studying virology, immunology and improving public health.
We continue to celebrate Sir Macfarlane Burnet achievements with the annual Burnet Prize, established in 1987 through a gift in Sir Macfarlane Burnet's will, and awarded to young scientists who have produced pioneering research.